Dexamethasone sodium phosphate Ophthalmic Solution Rx
Generic Name and Formulations:
Dexamethasone sodium phosphate 0.1%; oph soln; contains benzalkonium chloride.
Indications for Dexamethasone sodium phosphate Ophthalmic Solution:
Steroid responsive inflammatory conditions of the eye.
Initial therapy: 1 or 2 drops in conjunctival sac every hour during the day and every two hours during the night. When favorable response observed, reduce dose to 1 drop every 4 hours; may reduce later to 1 drop 3 or 4 times daily.
Epithelial herpes simplex keratitis. Acute infectious stages of vaccinia, varicella, and many other diseases of the cornea and conjunctiva. Mycobacterial infection of the eye. Fungal diseases of ocular or auricular structures. Perforation of a drum membrane.
Monitor intraocular pressure if used for >10 days. Wait at least 15 minutes before inserting contact lenses. Pregnancy (Cat.C). Nursing mothers: not recommended.
Glaucoma with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, perforation of the globe; rare: stinging, burning, filtering blebs following cataract surgery.
Endocrinology Advisor Articles
- FDA Approves Admelog Short-Acting Insulin Lispro Injection
- Fertility Hormone Therapy and Cardiovascular Outcomes: What We Know
- Effects of Peer Influence in Adolescents With Type 1 Diabetes
- More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes
- One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements
- FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels
- Injected and Oral Medications Equally Safe for Gestational Diabetes
- Adjunctive Dapagliflozin Improves Glycemic Control in T1D
- Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women
- Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death
- Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D
- Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes
- Oral Insulin Not a Reliable Preventive Strategy for Type 1 Diabetes
- Prevention of Bone Mineral Density Loss Needed in Epilepsy
- Gastric Bypass Blunts B-Cell Sensitivity During Glycemia